Cargando…
A PAF receptor antagonist inhibits acute airway inflammation and late-phase responses but not chronic airway inflammation and hyperresponsiveness in a primate model of asthma
We have examined the effects of a PAF receptor antagonist, WEB 2170, on several indices of acute and chronic airway inflammation and associated changes in lung function in a primate model of allergic asthma. A single oral administration WEB 2170 provided dose related inhibition of the release of leu...
Autores principales: | Gundel, R. H., Wegner, C. D., Heuer, H. O., Letts, L. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365364/ https://www.ncbi.nlm.nih.gov/pubmed/18475488 http://dx.doi.org/10.1155/S0962935192000577 |
Ejemplares similares
-
Is platelet activating factor (PAF) an important mediator in bronchial asthma?
por: Gundel, R. H., et al.
Publicado: (1992) -
The administration of clopidogrel attenuates airway hyperresponsiveness and airway inflammation in an ovalbumin specific allergic asthma model
por: Trinh, Hoang Kim Tu, et al.
Publicado: (2015) -
Concomitant Exposure to Ovalbumin and Endotoxin Augments Airway Inflammation but Not Airway Hyperresponsiveness in a Murine Model of Asthma
por: Mac Sharry, John, et al.
Publicado: (2014) -
Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways
por: Birrell, Mark A, et al.
Publicado: (2003) -
P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma
por: Suh, Dong‐Hyeon, et al.
Publicado: (2015)